Find the latest oncology news for your sub-specialty area
A single chemotherapy treatment can result in a significant negative impact on walking gait and…
High response rates to a pair of combination therapies point to potentially new options for…
A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a…
By Timothy J. Jorgensen, Georgetown University This past April, business traveler Tom Stuker became the…
About 50% of all cancer survivors and 70% of young breast cancer survivors report moderate…
In one of the first large studies to explore the possible impact of HPV vaccination…
Scientists may have developed the first targeted, oral, tumour-type agnostic therapy – a cancer medicine…
A clinical trial of nearly 2,000 men shows that adding abiraterone acetate (Zytiga) to a…
A randomized clinical trial of 766 patients shows that a simple intervention ̶ a web-based…
Findings from a phase III clinical trial of about 300 women may introduce PARP inhibitors…